NEW YORK (GenomeWeb News) – Transgenomic said today that it has licensed intellectual property from IntegraGen that it plans to use to develop a genetic test for autism risk in children who have older siblings who have already been diagnosed with an autism spectrum disorder.
Omaha, Neb.-based Transgenomic said that it will develop the test internally and expects it to be ready for launch by its CLIA-certified lab in the second quarter of 2010.
"We believe that the use of this test in conjunction with standard diagnostic tools will allow for the earlier diagnosis of autism, and importantly, the more timely initiation of treatment plans for these children," Transgenomic CEO and President Craig Tuttle said in a statement.
In addition to discovering genes and genetic variations for use in molecular diagnostic tests, Evry, France-based IntegraGen offers genotyping services to the research community.
Financial terms of the agreement were not released.